Biogen Inc logo

Biogen Inc - Cedear

NEW
BUE:BIIB (USA)   Cedear
ARS 25,060 +90 (+0.36%) Aug 6
36.51
P/B:
1.62
Market Cap:
ARS 45.60T ($ 30.42B)
Enterprise V:
ARS 56.18T ($ 37.48B)
Volume:
109.00
Avg Vol (2M):
1.59K
Trade In:
Volume:
109.00
Avg Vol (2M):
1.59K

Biogen Inc’s share price is ARS25060. Its GF Value is ARS23632.55. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Biogen Inc stock is .

The GF Value represents the current intrinsic value of a stock derived from our proprietary algorithm. It is based primarily on the historical multiples of where the stocks have been traded and the future growth of the business, adjusted for the past returns and growth. The GF Value has been verified by backtesting and daily updated model portfolios.

GF Value Growth:

In addition to considering the current valuation, the growth potential of a company's value is equally important. Companies with faster growth rates tend to increase their value more quickly. Therefore, it's essential to look at the Price-to-Future GF Value ratios as well. The results are shown below:

Price: ARS25060 GF Value Price/GF Value
Current ARS23632.55 1.06
Next FY1 End ARS24243.62 1.03
Next 12 Month ARS24581.35 1.02
Next FY2 End ARS24750.21 1.01
Correlation Analysis
Summary:

GuruFocus performed a correlation analysis comparing Biogen Inc's stock price with key financial metrics: revenue per share, book value per share, EPS without NRI, and operating cash flow per share.

The analysis reveals the strongest correlation between Biogen Inc's stock price and Book Value per share, with a coefficient of 77%. This is followed by a 72% correlation with Revenue per share and a 70% correlation with Operating Cash Flow per share. The weakest correlation is observed with Operating Cash Flow per share, at 68%.

Historical Trends of Key Valuation Ratios
GF Value of Related Companies